Sigma receptor

Classification

Because the σ-receptor was originally discovered to be agonized by benzomorphan opioids and antagonized by naltrexone, σ-receptors were originally believed to be a type of opioid receptor. When the σ1 receptor was isolated and cloned, it was found to have no structural similarity to the opioid receptors, but rather showed similarity to fungal proteins involved in sterol synthesis. At this point, they were designated as a separate class of proteins.

Putative sigma-3 receptor

In the early 1990s, a "sigma-3" binding site was proposed based on phenylaminotetralin (PAT) ligands and functional assays that linked PAT binding to stimulation of tyrosine hydroxylase and dopamine synthesis in rodent brain. Subsequent pharmacological and radioligand-binding studies demonstrated that these so-called sigma-3 sites correspond to histamine H1 receptors rather than a distinct sigma receptor subtype. As a result, contemporary classifications recognize only sigma-1 and sigma-2 receptors.

Function

The function of these receptors is poorly understood. Drugs known to be σ-agonists include cocaine, morphine/diacetylmorphine, opipramol, PCP, fluvoxamine, methamphetamine, dextromethorphan, and berberine. However, the exact role of σ-receptors is difficult to establish as many σ-agonists also bind to other targets such as the κ-opioid receptor and the NMDA glutamate receptor. In animal experiments, σ-antagonists such as rimcazole were able to block convulsions from cocaine overdose. σ-antagonists are also under investigation for use as antipsychotic medications. Early rodent studies reported that σ-receptor ligands can functionally antagonize opioid analgesia: (+)-pentazocine and 1,3-di(2-tolyl)guanidine reduced morphine analgesia in a haloperidol-reversible, D2-independent manner, consistent with a tonically active anti-opioid σ1 system.

The abundant neurosteroid steroid hormone DHEA is an agonist at sigma receptors and along with pregnenolone could be endogenous agonist ligands; opposed by sigma antagonistic activity from progesterone. Another endogenous ligand, N,N-dimethyltryptamine, was also found to interact with σ1.

Physiologic effects

Physiologic effects when the σ-receptor is activated include hypertonia, tachycardia, tachypnea, antitussive effects, and mydriasis. Some σ-receptor agonists—such as cocaine, a weak σ-agonist—exert convulsant effects in animals.

In 2007, selective σ-receptor agonists were shown to produce antidepressant-like effects in mice.

σ-receptors were also shown to have a role in the regulation of iron/heme homeostasis.

In mice, σ1 activation attenuated μ-, κ-, and δ-opioid analgesia without altering morphine's effects on gastrointestinal transit or lethality, while σ blockade with haloperidol enhanced analgesia and eliminated strain differences in κ-agonist sensitivity.

Ligands

Agonists

• Choline{{ cite web | url = https://www.sciencedaily.com/releases/2019/01/190114113529.htm | title = Researchers identify long-sought activator of sigma receptors in human cells | access-date = 2022-03-14 | date = 2019-01-14}}

• 3-MeO-PCP: selective for σ1 subtype, Ki = 42nM

• 4-PPBP

• Afobazole: selective for σ1 subtype

• Allylnormetazocine (SKF-10047)

• Amantadine

• Amitriptyline

• Anavex 2-73

• Arketamine

• BD1031: selective for σ1 subtype

• BD1052: selective for σ1 subtype

• Berberine

• Citalopram

• Cocaine

• Dehydroepiandrosterone (DHEA)

• Dehydroepiandrosterone sulfate (DHEA-S)

• Dextromethorphan (DXM): relatively selective for σ1 subtype

• Dextrorphan

• N,N-Dimethyltryptamine (DMT)

• Dimemorfan

• Ditolylguanidine

• Escitalopram

• Fluoxetine

• Fluvoxamine

• Igmesine

• Ketamine

• L-687,384: selective for σ1 subtype (& Spipethiane).

• Memantine: selective for σ1 subtype, low affinity

• Methamphetamine

• Methoxymethylenedioxyethylcyclohexamine (MDXC)

• Methylphenidate

• Noscapine

• OPC-14523

• Opipramol

• PB-28: selective for σ2 subtype

• Pentazocine

• Pentoxyverine: selective for σ1 subtype

• Phencyclidine

• (+)-3-PPP

• PRE-084: selective for σ1 subtype

• Pregnenolone

• Pregnenolone sulfate

• SA 4503: selective for σ1 subtype

• Siramesine

• UMB23

• UMB82

Antagonists

• AC927
• AHD1
• AZ-66
• BD1008
• BD-1047: selective for σ1 subtype
• BD1060: selective for σ1 subtype
• BD1063: selective for σ1 subtype
• BD1067
• BMY-14802
• CM156: 3-(4-(4-cyclohexylpiperazin-1-yl)butyl)benzo[d]thiazole-2(3H)-thione
• E-5842
• Haloperidol
• LR132: selective for σ1 subtype
• LR172
• MS-377: selective for σ1 subtype
• NE-100: selective for σ1 subtype
• Panamesine
• Phenothiazines
• Progesterone
• Rimcazole
• S1RA (E-52862): selective for σ1 subtype
• Sertraline
• UMB 98 & UMB 99
• UMB100
• UMB101
• UMB103
• UMB116
• YZ-011
• YZ-067
• YZ-069
• YZ-185

References

References

1. (May 2007). "Sigma receptor agonists provide neuroprotection in vitro by preserving bcl-2". Anesthesia and Analgesia.
2. (February 2009). "The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator". Science.
3. (June 2006). "The synergistic effect of selective sigma receptor agonists and uncompetitive NMDA receptor antagonists in the forced swim test in rats". Journal of Physiology and Pharmacology.
4. (1994-11-25). "Conformational analysis, pharmacophore identification, and comparative molecular field analysis of ligands for the neuromodulatory sigma 3 receptor". Journal of Medicinal Chemistry.
5. (1995-09-15). "1-Phenyl-3-amino-1,2,3,4-tetrahydronaphthalenes and related derivatives as ligands for the neuromodulatory sigma-3 receptor: further structure–activity relationships". Journal of Medicinal Chemistry.
6. (1999-08-07). "Putative sigma(3) sites in mammalian brain have histamine H(1) receptor properties: evidence from ligand binding and distribution studies with the novel H(1) radioligand [(3)H]-(-)-trans-1-phenyl-3-aminotetralin". Brain Research.
7. (2014). "TM6SF2 and MAC30, new enzyme homologs in sterol metabolism and common metabolic disease.". Frontiers in Genetics.
8. (July 2009). "Identification of Cholesterol-Regulating Genes by Targeted RNAi Screening". Cell Metabolism.
9. (2017). "Sigma Proteins: Evolution of the Concept of Sigma Receptors". Springer International Publishing.
10. (July 1996). "Purification, molecular cloning, and expression of the mammalian sigma1-binding site". Proceedings of the National Academy of Sciences of the United States of America.
11. (November 2004). "Sigma receptors and sigma ligands: background to a pharmacological enigma". Pharmacopsychiatry.
12. (1993-11-30). "Functional antagonism of morphine analgesia by (+)-pentazocine: evidence for an anti-opioid sigma 1 system". European Journal of Pharmacology.
13. (1994). "Selective antagonism of opioid analgesia by a sigma system". Journal of Pharmacology and Experimental Therapeutics.
14. (July 2004). "Sigma receptors: biology and therapeutic potential". Psychopharmacology.
15. (February 2009). "The hallucinogen N,N-dimethyltryptamine (DMT) is an endogenous sigma-1 receptor regulator". Science.
16. (November 2007). "Novel sigma (sigma) receptor agonists produce antidepressant-like effects in mice". European Neuropsychopharmacology.
17. (January 2023). "Sigma Receptors: Novel Regulators of Iron/Heme Homeostasis and Ferroptosis". International Journal of Molecular Sciences.
18. (2012-10-18). "(ACMD) Methoxetamine Report (2012)". UK Home Office.
19. (November 2009). "The pharmacology of sigma-1 receptors". Pharmacology & Therapeutics.
20. (February 1997). "Differential psychopathology and patterns of cerebral glucose utilisation produced by (S)- and (R)-ketamine in healthy volunteers using positron emission tomography (PET)". European Neuropsychopharmacology.
21. (October 1990). "Evidence of a role for NMDA receptors in pain perception". European Journal of Pharmacology.
22. (April 2004). "Involvement of the sigma 1 receptor in the modulation of dopaminergic transmission by amantadine". The European Journal of Neuroscience.
23. (2012). "Methylphenidate enhances NMDA-receptor response in medial prefrontal cortex via sigma-1 receptor: a novel mechanism for methylphenidate action". PLOS ONE.
24. (Oct–Dec 1996). "Role of opioidergic and serotonergic mechanisms in cough and antitussives". Pulmonary Pharmacology.
25. (May 2010). "A novel substituted piperazine, CM156, attenuates the stimulant and toxic effects of cocaine in mice". The Journal of Pharmacology and Experimental Therapeutics.
26. (May 2019). "Sigma-1 Receptor Antagonists Haloperidol and Chlorpromazine Modulate the Effect of Glutoxim on Na⁺ Transport in Frog Skin". Doklady. Biochemistry and Biophysics.
27. (May 2004). "Novel analogs of the sigma receptor ligand BD1008 attenuate cocaine-induced toxicity in mice". Eur J Pharmacol.
28. (August 2006). "N-[2-(m-methoxyphenyl)ethyl]-N-ethyl-2-(1-pyrrolidinyl)ethylamine (UMB 116) is a novel antagonist for cocaine-induced effects". Eur J Pharmacol.
29. (March 2020). "The sigma receptor ligand N-phenylpropyl-N'-(4-methoxyphenethyl)3piperazine (YZ-067) enhances the cocaine conditioned-rewarding properties while inhibiting the development of sensitization of cocaine in mice". Psychopharmacology (Berl).
30. (April 2004). "Structure-activity comparison of YZ-069, a novel sigma ligand, and four analogs in receptor binding and behavioral studies". Pharmacol Biochem Behav.
31. (2013). "N-Phenylpropyl-N'-(3-methoxyphenethyl)piperazine (YZ-185) Attenuates the Conditioned-Rewarding Properties of Cocaine in Mice". ISRN Pharmacol.